Thursday, October 3, 2024
HomeHealth ConditionsCold and FluCan obesity make the flu worse?

Can obesity make the flu worse?

Population obesity in mice allows more virulent strains of influenza to develop and spread.

The countless negative health impacts of obesity have mostly been well documented. However, one of the less well known harmful effects of obesity is the impact it can have on viral pathogenesis. Population-based studies of the 2009 Swine Flu pandemic suggest obese individuals suffered more severely when contracting the H1N1 influenza strain. Having a BMI over 30 was associated with more time spent in hospital, increased complications, and a higher mortality rate.

These observations are largely explained by the fact that obesity suppresses the body’s natural immune responses. Obese individuals can therefore theoretically provide a uniquely hospitable host environment that allows for the development of more potent viral strains. This theory is explored in a new study published in the journal mBio, a journal of the American Society of Microbiology (1).

To test the hypothesis that more virulent strains develop in obese populations, the research team passed the same strain of influenza A through two distinct mice population types, an obese population and a lean population. The obese population was made up of either genetically-induced obese mice or mice that had been fed an obesity-inducing diet. For comparison, the influenza A strain was also passed through a population of lean mice. Passing through a population requires the virus to replicate within the population. As the environment in a lean host is different and more difficult for the virus to replicate within, minor differences emerge between the viral strains across the two populations.

Wild-type mice were then infected with these emergent strains. The viral strains that had developed in the obese population were more virulent and caused greater morbidity in the wild-type mice than the strains that had emerged from the lean populations.

The viral strains were also sequenced with the strains emerging from the obese populations showing several mutations associated with greater virulence. Furthermore, the research team attempted to repeat their results in human cells obtained from obese donors and lean donors. Again, the influenza virus replicated in higher numbers in the human cells obtained from obese donors than it did in cells obtained from lean donors.

A potential mechanism by which the viruses are allowed to replicate more easily in obese cells was also highlighted. Obese mice and cells from obese human donors both demonstrated reductions in interferon and interferon-stimulated-genes post-infection compared to lean cells. Interferons are signalling proteins that help to activate the body’s immune response to viral infection. With these signals turned down by obesity, the immune response to viral infection is reduced. This, in turn, appears to allow the virus greater freedom to replicate.

The results of this study are particularly interesting for a number of reasons. Firstly, it has been well documented that obesity impacts how a host deals with an infection (viral, fungal bacterial, etc.). However, this study examines this from a different perspective and demonstrates how an obese host can impact on the virus itself. As up to 50% of the world’s adult population is currently classified as overweight or obese, the results of this study could have significant implications for global health.

The world is currently in the midst of a high-profile viral pandemic. The spread of coronavirus SARS-CoV-2 has shown how quickly a novel virus can spread. In recent years, obesity has become a global epidemic. Although these conditions may appear unrelated, this study demonstrates that the obesity epidemic may in fact put global health at greater risk of future, even more virulent viral outbreaks.

Written by Michael McCarthy

References

  1. Honce R, Karlsson EA, Wohlgemuth N, Estrada LD, Meliopoulos VA, Yao J, et al. Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains. mBio. 2020;11(2):e03341-19.

Image by moritz320 from Pixabay 

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News and Articles

SUBSCRIBE TO OUR NEWSLETTERS

Stay Connected
10,288FansLike
820FollowersFollow
249FollowersFollow
2,787FollowersFollow

Article of the month

ANKTIVA Boosts BCG for Bladder Cancer

The FDA has approved the immunotherapy-boosting drug, ANKTIVA, to be used with the existing immunotherapy drug, Bacillus Calmette-Guerin (BCG). This new therapy is a...

Joke Of The Day

Patient: Doctor, can you prescribe me something to stop me from sleepwalking? Doctor: No, you need the exercise!

ADVERTISE WITH US

error: Content is read-only and copy-protected.